Long-term seventh molecular remission in acute promyelocytic leukaemia. 2011

Laura Cicconi, and Atelda Romano, and Safaa M Ramadan, and Mariadomenica Divona, and Maria Concetta Petti, and Francesco Lo-Coco

UI MeSH Term Description Entries
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014212 Tretinoin An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). Retinoic Acid,Vitamin A Acid,Retin-A,Tretinoin Potassium Salt,Tretinoin Sodium Salt,Tretinoin Zinc Salt,Vesanoid,all-trans-Retinoic Acid,beta-all-trans-Retinoic Acid,trans-Retinoic Acid,Acid, Retinoic,Acid, Vitamin A,Acid, all-trans-Retinoic,Acid, beta-all-trans-Retinoic,Acid, trans-Retinoic,Potassium Salt, Tretinoin,Retin A,Salt, Tretinoin Potassium,Salt, Tretinoin Sodium,Salt, Tretinoin Zinc,Sodium Salt, Tretinoin,Zinc Salt, Tretinoin,all trans Retinoic Acid,beta all trans Retinoic Acid,trans Retinoic Acid
D015473 Leukemia, Promyelocytic, Acute An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION. Leukemia, Myeloid, Acute, M3,Leukemia, Progranulocytic,Myeloid Leukemia, Acute, M3,Progranulocytic Leukemia,Promyelocytic Leukemia, Acute,AML M3,Acute Promyelocytic Leukemia,Leukemia, Acute Promyelocytic,M3 ANLL,ANLL, M3,Acute Promyelocytic Leukemias
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Laura Cicconi, and Atelda Romano, and Safaa M Ramadan, and Mariadomenica Divona, and Maria Concetta Petti, and Francesco Lo-Coco
October 1970, Lancet (London, England),
Laura Cicconi, and Atelda Romano, and Safaa M Ramadan, and Mariadomenica Divona, and Maria Concetta Petti, and Francesco Lo-Coco
March 1984, Lancet (London, England),
Laura Cicconi, and Atelda Romano, and Safaa M Ramadan, and Mariadomenica Divona, and Maria Concetta Petti, and Francesco Lo-Coco
April 1999, Leukemia,
Laura Cicconi, and Atelda Romano, and Safaa M Ramadan, and Mariadomenica Divona, and Maria Concetta Petti, and Francesco Lo-Coco
March 2002, Leukemia & lymphoma,
Laura Cicconi, and Atelda Romano, and Safaa M Ramadan, and Mariadomenica Divona, and Maria Concetta Petti, and Francesco Lo-Coco
September 2003, Best practice & research. Clinical haematology,
Laura Cicconi, and Atelda Romano, and Safaa M Ramadan, and Mariadomenica Divona, and Maria Concetta Petti, and Francesco Lo-Coco
October 2010, British journal of haematology,
Laura Cicconi, and Atelda Romano, and Safaa M Ramadan, and Mariadomenica Divona, and Maria Concetta Petti, and Francesco Lo-Coco
December 1995, British journal of haematology,
Laura Cicconi, and Atelda Romano, and Safaa M Ramadan, and Mariadomenica Divona, and Maria Concetta Petti, and Francesco Lo-Coco
October 2001, British journal of haematology,
Laura Cicconi, and Atelda Romano, and Safaa M Ramadan, and Mariadomenica Divona, and Maria Concetta Petti, and Francesco Lo-Coco
January 1992, Nouvelle revue francaise d'hematologie,
Laura Cicconi, and Atelda Romano, and Safaa M Ramadan, and Mariadomenica Divona, and Maria Concetta Petti, and Francesco Lo-Coco
March 1974, British medical journal,
Copied contents to your clipboard!